NCT04604067
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04604067
Title Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial.
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Swiss Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA | CHE

Facility Status City State Zip Country Details
Ospedale Papa Giovanni XXIII Bergamo 24127 Italy Details
Azienda Ospedaliera Universitaria Maggiore della Carita di Novara Novara 20503 Italy Details
Policlinico Agostino Gemelli Roma 00168 Italy Details
Kantonsspital Aarau Aarau CH-5001 Switzerland Details
Kantonsspital Baden (Baden/Brugg) Baden 5404 Switzerland Details
St. Claraspital Basel 4058 Switzerland Details
Istituto Oncologico della Svizzera Italiana Bellinzona 6500 Switzerland Details
Inselspital, Bern Bern CH-3010 Switzerland Details
Kantonsspital Graubünden Chur 7000 Switzerland Details
Hopital Fribourgeois Fribourg 1708 Switzerland Details
Hopitaux Universitaire de Genève (HUG) Geneva 1211 Switzerland Details
Centre Hospitalier Universitaire Vaudois Lausanne CH-1011 Switzerland Details
Kantonsspital Luzern Luzerne CH-6000 Switzerland Details
Réseau Hospitalier Neuchâtelois (RHNe) Neuchâtel 2000 Switzerland Details
Kantonsspital Olten Olten CH-4600 Switzerland Details
Kantonsspital St. Gallen Sankt Gallen 9007 Switzerland Details
Kantonsspital Winterthur Winterthur 8401 Switzerland Details
UniversitätsSpital Zürich Zurich 8091 Switzerland Details
City Hospital Triemli Zurich CH-8063 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field